cagrisema cagrilintide semaglutide phase 3 results 2024 2025 Efficacy and safety of once-weekly cagrilintide–semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, 3a study cagrisema cagrilintide semaglutide phase 3

US$ 24.81

★★★★★ 4.8 (6 reviews)

US$ 21.48

★★★★★ 4.3 (9 reviews)

US$ 22.26

★★★★★ 4.1 (29 reviews)

US$ 27.93

★★★★★ 4.7 (27 reviews)

US$ 28.28

★★★★★ 4.3 (6 reviews)

US$ 24.64

★★★★★ 4.5 (23 reviews)

US$ 29.32

★★★★★ 4.9 (15 reviews)

US$ 27.41

★★★★★ 4.8 (17 reviews)

US$ 22.61

★★★★★ 4.2 (26 reviews)

US$ 26.16

★★★★★ 4.6 (19 reviews)

US$ 24.09

★★★★★ 5.0 (20 reviews)

US$ 28.05

★★★★★ 4.3 (9 reviews)

US$ 27.79

★★★★★ 4.6 (12 reviews)

US$ 24.81

★★★★★ 5.0 (26 reviews)

US$ 20.18

★★★★★ 4.8 (18 reviews)

US$ 26.19

★★★★★ 4.0 (14 reviews)

US$ 24.30

★★★★★ 4.8 (28 reviews)

US$ 27.25

★★★★★ 4.7 (17 reviews)

US$ 27.89

★★★★★ 4.6 (18 reviews)

US$ 27.50

★★★★★ 4.3 (8 reviews)